Abstract
Background
Xerostomia is a subjective sensation of mouth dryness that may frequently occur in older patients.
Objective
To compare the clinical efficacy and acceptability of a new oxygenated glycerol triester (OGT) oral spray taken five times daily with that of a commercially available saliva substitute (Saliveze®) in the treatment of xerostomia.
Methods
Forty-one institutionalised patients (28 women, 13 men; mean age 84 ± 7 years) were randomly assigned to receive either OGT or Saliveze® in a 2-week, randomised, parallel-group study. Clinical assessment of xerostomia included evaluation of mouth dryness using a self-rated, 10cm long visual analogue scale (VAS), objective assessment of oral tissue condition using a four-point ordinal scale and subjective assessment of symptoms of xerostomia using dichotomous responses to a questionnaire. The primary endpoint was the day (D) 14 patient-based mouth dryness score measured on a self-rated VAS.
Results
At D14, OGT resulted in significantly greater efficacy with respect to mouth dryness (mean between-treatment difference 2.1 ± 0.1, 95% CI 1.9, 2.3; p = 0.001), swallowing difficulty (1.8 ± 0.3, 95% CI 1.5, 2.1; p = 0.001), speech difficulty (1.1 ± 0.2, 95% CI 1.0, 2.4; p = 0.04) and overall sensation of symptom relief (2.7 ± 1.2, 95% CI 1.9, 3.8; p = 0.001). Objective assessment of oral tissues also showed significantly better improvement with OGT spray with respect to dryness (p = 0.01), stickiness (p = 0.005) and dullness (p = 0.001) of oral mucosa; severity of mucositis (p = 0.01); and thickening of the tongue (p = 0.03). A significant difference in taste acceptability was also noted in favour of OGT (1.4 ± 0.6, 95% CI 1.2, 1.9; p = 0.04).
Conclusion
OGT lubricant oral spray was superior to Saliveze® in improving xerostomia and oral tissue condition in older institutionalised patients.
Similar content being viewed by others
Notes
The use of trade names is for product identification purposes only and does not imply endorsement.
References
Navazesh M, Denny P, Sobel S. Saliva: a fountain of opportunity. J Calif Dent Assoc 2002; 30: 783–8
Mason DK, Chishlom DM. Salivary glands and their secretions. In: Mason DK, Chishlom DM, editors. Salivary glands in health and disease. London: Saunders, 1975: 3–69
Wilborn WH, Schackleford JM. Microanatomy of human salivary glands. In: Manaken L, editor. The biologic basis of dental caries. Hagerstown: Harper & Row, 1980: 3–62
Madinier I, Jehl-Pietri C, Monteil RA. Les hyposialies d’origine medicamenteuse. Ann Med Int 1997; 148: 398–405
Handelman SL, Baric JM, Espeland MA, et al. Prevalence of drugs causing hyposalivation in an institutionalized geriatric population. Oral Surg Oral Med Oral Pathol 1986; 62: 26–31
Hendelman SL, Baric JM, Saunders RH, et al. Hyposalivary drug use, whole stimulated salivary flow and mouth dryness in older long-term care residents. Spec Care Dent 1989; 1: 12–8
Mornstad H, Von Knorring L, Forsgren L, et al. Long-term effects of two principally different antidepressant drugs on saliva secretion and composition. Scand J Dent Res 1986; 94: 461–70
Sreeby LM, Valdini A, Yu A. Xerostomia: part II. Relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol 1989; 68: 419–27
Fox PC. Management of dry mouth. Dent Clin North Am 1997; 41: 863–75
Matear DW, Locker D, Stephens M, et al. Associations between xerostomia and health status indicators in the elderly. J R Soc Health 2006; 126: 79–85
Rejnefelt I, Andersson P, Renvert S. Oral health status in individuals with dementia living in special facilities. Int J Dent Hyg 2006; 4: 67–71
Locker D. Xerostomia in older adults: a longitudinal study. Gerodontology 1995; 12: 18–25
Peltola P, Vehkalahti MM, Wuolijoki-Saaristo K. Oral health and treatment needs of the long-term hospitalized elderly. Gerodontology 2004; 21: 93–9
Sreenby LM, Valdini A. Xerostomia: a neglected symptom. Arch Int Med 1987; 147: 1333–7
Guijarro Guijarro B, Lopez Sanchez AF, Hernandez Vallejo G. Treatment of xerostomia: a review. Med Oral 2001; 6: 7–18
Navazesh M. Dry mouth: aging and oral health. Compend Contin Educ Dent 2002; 23: 41–8
Andersson G, Johansson G, Attstrom R, et al. Comparison of the effect of the linseed extract salinum and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology 1995; 12: 12–7
Niedermeier W, Huber M, Fischer D, et al. Significance of saliva for the denture-wearing population. Gerodontology 2000; 17: 104–18
Epstein JB, Emerton S, Le ND, et al. A open-labelled crossover trial of oral balance gel and biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999; 35: 132–7
Navazesh M, ADA Council on Scientific Affairs and Division of Science. How can oral health care providers determine if patients have dry mouth? J Am Dent Assoc 2003; 134: 613–20; quiz 633
Epstein JB, Scully C. The role of saliva in oral health and the causes and effects of xerostomia. J Can Dent Assoc 1992; 58: 217–21
Vered M, Buchner A, Boldon P, et al. Age-related histomorphometric changes in labial salivary glands with special reference to the acinar component. Exp Gerontol 2000; 35: 1075–84
Moreira CR, Azevedo LR, Lauris JR, et al. Quantitative age-related differences in human sublingual gland. Arch Oral Biol 2006; 51: 960–6
Nyarady Z, Nemeth A, Ban A, et al. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer. Anti-cancer Res 2006; 26: 1557–62
Sweeney MP, Bagg J, Baxter WP, et al. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 1997; 11: 225–32
Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med 2000; 14: 197–203
Moritsuka M, Kitasako Y, Burrow MF, et al. Quantitative assessment for stimulated saliva flow rate and buffering capacity in relation to different ages. J Dent 2006; 34: 716–20
Davies AN, Daniels C, Pugh R, et al. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med 1998; 12: 105–11
Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary hypofunction. J Dent Res 1992; 71: 1363–9
Meyer-Lueckel H, Kielbassa AM. Utilisation de succedanes salivaires chez les patients souffrant de xerostomie. Rev Mens Suisse Odontostomatol 2002; 112: 1049–58
Navazesh M. Xerostomia in the aged. Dent Clin North Am 1989; 33: 75–80
Acknowledgements
This study was funded by Laboratoires Carilène, Montesson, France. The authors are indebted to the nurses at the Department of Geriatry, Clinique Leopold Bellan, Magnanville, France for their precious contribution to the study. Dr Stéphane Mouly received an honorarium from Laboratoires Carilène for preparation of the article. Dr Anne-Claude Coudert and Dr Stéphane Desjonquères are employees of Laboratoires Carilène. The other authors have no conflicts of interest that are directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mouly, S., Salom, M., Tillet, Y. et al. Management of Xerostomia in Older Patients. Drugs Aging 24, 957–965 (2007). https://doi.org/10.2165/00002512-200724110-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200724110-00007